Evaluate the Safety and Efficacy of Phenazopyridine Hydrochloride Tablets, USP 200 mg vs. Placebo
This study has been completed.
Sponsor:
Amneal Pharmaceuticals, LLC
Collaborators:
Oxford Pharmaceutical Resources, Inc.
Sristek Clinical Research
Biostudy Solutions, LLC
Information provided by (Responsible Party):
Amneal Pharmaceuticals, LLC
ClinicalTrials.gov Identifier:
NCT01064024
First received: February 4, 2010
Last updated: January 24, 2013
Last verified: January 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | December 2010 |
| Primary Completion Date: | December 2010 (Final data collection date for primary outcome measure) |
| Certification or Request for Extension to Delay Results Received: | January 24, 2013 |